Practice making decisions with the 2018 patient algorithm in this interactive case discussion. Featuring local-level commentary for France, Spain and Italy.
Continue to practice your decision-making when intensifying treatment beyond triple therapy. Featuring local commentary from France, Spain and Italy.
Consider clinical decision-making in a complex case and theoretical future scenarios. Featuring local commentary from France, Spain and Italy.
The 2018 ADA/EASD guidelines have provided a patient algorithm to simplify and revolutionise patient care, providing an individualised approach in a time-efficient manner. But how should this guidance be implemented in practice? How should you use the algorithm to make clinical decisions?
This 4-part digital symposium summarises new treatment directions and the considerations required in treating type 2 diabetes. You can complete this alone or together with colleagues using the symposium's discussion guide, available to download from the module information page.
A comprehensive overview of GLP-1 receptor agonists, including mechanism of action, multifactorial effects and how to predict response to their use in type 2 diabetes.
A summary of guideline recommendations in the use of GLP-1 analogues, including how to help patients manage gastrointestinal side effects.
A comprehensive summary of relevant data across GLP-1RAs, SGLT2 inhibitors and DPP-4 inhibitors, complete with guidance on how to select between these.
A review of data surrounding once-weekly GLP-1 receptor agonists, including clinical trial data and how these apply to the real world.
A summary of up-and-coming next generation GLP-1 RAs, clinical trial data associated with these and future perspectives on how they may impact practice.